Two major U.S. pharmaceutical companies possess heightened bankruptcy risk largely due to lawsuits stemming from the opioid crisis. Our models are reflexive enough to give the most accurate forward-looking reads on financial risk when calamities strike.
Over the last two completed calendar years, CreditRiskMonitor's FRISK® score was able to predict U.S. public company bankruptcy at a near 98% rate of success.
As part of our look back at the year that was in 2018, the arrival of the PAYCE® score changed the way our subscribers monitored private company financial risk.
Chicago-based pharmaceutical leader Akorn, Inc. has seen its FRISK® score freefall down from a "9" to a "1" in a year's time.
Is Community Health Systems, Inc. on life support? Our High Risk Report offers a prognosis on this volatile American healthcare provider.
A contraction in credit is not something that might occur: It will happen at some point. Risk professionals dealing with the healthcare sector are better off preparing now, while economic conditions are still strong.
CreditRiskMonitor’s FRISK® score had been warning of tremendous financial stress at healthcare provider Hooper Holmes, Inc. for more than a year's time before their bankruptcy filing in late August.
California-based biopharmaceutical company Orexigen Therapeutics, Inc. failed to pass our FRISK® score inspection for years, ultimately filing for bankruptcy in early 2018.
A recent study of the last two completed calendar years showed that CreditRiskMonitor's FRISK® score was able to predict U.S. public company bankruptcy at a 97.9% rate of success.
In 2016, there were more than 50 million people 65-or-older living in the United States. Although the post-acute healthcare industry is still growing along with its prime customer base, this fiercely competitive service industry remains a highly fragmented market.
Public company credit risk is more pervasive than you think. Do you know how much is in your portfolio?
Adeptus Health recently filed for bankruptcy and creditors may have missed the early warning signs. Adeptus Health's FRISK® score, however, caught the trouble as it signaled increasing financial risk over the last twelve months.